Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

90.64

+3.43 (3.93%)

At close: May 20, 2026, 4:00 PM EDT

92.99

+2.35 (2.59%)

After-hours: May 20, 2026, 4:49 PM EDT

Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	6,212	7,194	3,493	2,732	1,649	502
Market Cap Growth	52.54%	105.97%	27.85%	65.71%	228.51%	-61.84%
Enterprise Value	5,981	6,939	3,319	2,456	1,317	208.92
Last Close Price	90.64	107.04	55.98	45.97	29.12	9.98
PS Ratio	28.59	37.91	26.84	35.28	69.74	159.11
PB Ratio	48.57	51.73	160.74	16.09	6.24	1.77
P/TBV Ratio	48.82	50.02	157.14	15.62	5.74	1.74
EV/Sales Ratio	27.54	36.57	25.50	31.73	55.70	66.24
Debt / Equity Ratio	0.01	0.01	0.02	0.00	0.00	0.01
Net Debt / Equity Ratio	-2.74	-2.77	-14.57	-1.62	-1.25	-1.03
Net Debt / EBITDA Ratio	1.72	2.02	1.20	1.50	1.87	1.73
Net Debt / FCF Ratio	2.82	3.30	2.78	2.02	1.91	2.00
Asset Turnover	0.47	0.43	0.36	0.22	0.07	0.01
Inventory Turnover	0.85	0.88	0.98	1.61	1.41	10.79
Quick Ratio	3.63	3.92	2.94	5.27	8.53	6.81
Current Ratio	4.17	4.41	3.24	5.58	8.90	7.10
Return on Equity (ROE)	-79.85%	-90.45%	-155.91%	-85.10%	-66.05%	-30.89%
Return on Assets (ROA)	-42.99%	-44.13%	-73.34%	-51.71%	-50.32%	-65.84%
Return on Invested Capital (ROIC)	-14205.90%	3915.44%	-112176.00%	-2424.57%	-3462.31%	7853.11%
Return on Capital Employed (ROCE)	-55.34%	-58.99%	-95.80%	-59.45%	-56.99%	-74.72%
Buyback Yield / Dilution	-7.27%	-6.54%	-5.76%	-10.65%	-5.08%	-12.40%
Total Shareholder Return	-7.27%	-6.54%	-5.76%	-10.65%	-5.08%	-12.40%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q